CompletedPhase 4NCT00627380
Yoga for the Management of HIV-Metabolic Syndromes
Studying Lipodystrophy due to peptidic growth factors deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Washington University School of Medicine
- Principal Investigator
- Kevin E Yarasheski, PhDWashington University School of Medicine
- Intervention
- Yoga lifestyle intervention(behavioral)
- Enrollment
- 60 enrolled
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2005 – 2009
Study locations (1)
- Washington University School of Medicine, St Louis, Missouri, United States
Collaborators
National Center for Complementary and Integrative Health (NCCIH)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00627380 on ClinicalTrials.govOther trials for Lipodystrophy due to peptidic growth factors deficiency
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07091734Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024University of Michigan
- RECRUITINGNCT02325674MEASuRE: Metreleptin Effectiveness And Safety RegistryAmryt Pharma
See all trials for Lipodystrophy due to peptidic growth factors deficiency →